| scholarly article | Q13442814 |
| P50 | author | Florian Greten | Q17321656 |
| Tiffany N Seagroves | Q73088022 | ||
| P2093 | author name string | M. Karin | |
| R. Johnson | |||
| Y. Cao | |||
| E. V. Schmidt | |||
| G. Bonizzi | |||
| P2860 | cites work | B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50 | Q24316476 |
| Limb and skin abnormalities in mice lacking IKKalpha | Q42470314 | ||
| IKKalpha controls formation of the epidermis independently of NF-kappaB. | Q42502421 | ||
| IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis | Q46607308 | ||
| Mammary glands of Aly mice: developmental changes and lactation-related expression of specific proteins, alpha-casein, GLyCAM-1 and MAdCAM-1. | Q52166546 | ||
| Genetics of RAS signaling in C. elegans. | Q52182134 | ||
| Cyclin D1 provides a link between development and oncogenesis in the retina and breast | Q52206604 | ||
| Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. | Q52542561 | ||
| Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. | Q53461014 | ||
| Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3 | Q73540287 | ||
| IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation | Q24321727 | ||
| A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB | Q24321775 | ||
| IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK | Q24321797 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation | Q24650561 | ||
| Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity | Q27860643 | ||
| NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 | ||
| Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation | Q28140878 | ||
| The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 | ||
| Complete reconstitution of human IkappaB kinase (IKK) complex in yeast. Assessment of its stoichiometry and the role of IKKgamma on the complex activity in the absence of stimulation | Q28208562 | ||
| Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway | Q28214369 | ||
| The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation | Q28252726 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. | Q33959017 | ||
| Specific protection against breast cancers by cyclin D1 ablation | Q34082446 | ||
| The I kappa B kinase: a master regulator of NF-kappa B, innate immunity, and epidermal differentiation. | Q34170916 | ||
| Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions | Q34295503 | ||
| Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice | Q34342812 | ||
| Signaling pathways in mammary gland development. | Q34434909 | ||
| C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. | Q35202739 | ||
| An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis | Q35834615 | ||
| Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium | Q36283770 | ||
| The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis | Q36368249 | ||
| Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture | Q36400143 | ||
| Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses | Q36400158 | ||
| Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth | Q36569036 | ||
| Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer | Q37376029 | ||
| NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition | Q39445143 | ||
| Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells | Q39795545 | ||
| The Ras signaling pathway in Drosophila | Q40525097 | ||
| NF-kappaB inhibits apoptosis in murine mammary epithelia | Q40884614 | ||
| Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase | Q40954925 | ||
| Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice | Q40956523 | ||
| Severe liver degeneration in mice lacking the IkappaB kinase 2 gene | Q40962152 | ||
| Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase | Q41644582 | ||
| IkappaB kinase alpha is essential for mature B cell development and function | Q42175977 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cyclin D1 | Q15311866 |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | Q21495135 | ||
| P304 | page(s) | 763–775 | |
| P577 | publication date | 2001-12-14 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development | |
| P478 | volume | 107 |
| Q24338768 | A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1 |
| Q24676875 | A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas |
| Q28592979 | A dual role for Ikk alpha in tooth development |
| Q35575883 | A lymphotoxin-driven pathway to hepatocellular carcinoma |
| Q25257805 | A new method for gene discovery in large-scale microarray data |
| Q24603716 | A novel role of IKKalpha in the mediation of UVB-induced G0/G1 cell cycle arrest response by suppressing Cyclin D1 expression |
| Q45023570 | A novel ubiquitin-like domain in IkappaB kinase beta is required for functional activity of the kinase |
| Q36439454 | A potential role of progestin-induced laminin-5/α6-integrin signaling in the formation of side branches in the mammary gland |
| Q58965963 | A regulator branches out |
| Q37811890 | A single NFκB system for both canonical and non-canonical signaling |
| Q24316467 | A20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activity |
| Q40076402 | ATM is required for SOD2 expression and homeostasis within the mammary gland. |
| Q24562579 | Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers |
| Q37441340 | Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection |
| Q92494933 | Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis |
| Q36655984 | Alveolar and lactogenic differentiation |
| Q37019189 | An IKKα-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence |
| Q53392614 | An essential link to mammary cancer? |
| Q38075495 | Animal model for mammary tumor growth in the bone microenvironment |
| Q35854115 | Apoptosis regulation in the mammary gland |
| Q90356595 | Association of Genetic Variants in NF-kB with Susceptibility to Breast Cancer: a Case Control Study |
| Q40251957 | Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis |
| Q34366449 | Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond |
| Q35145622 | Biology of the TRANCE axis |
| Q37548680 | Bone marrow-specific knock-in of a non-activatable Ikkα kinase mutant influences haematopoiesis but not atherosclerosis in Apoe-deficient mice |
| Q37647096 | CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters. |
| Q89293747 | Cdc48/p97 segregase is modulated by cyclin-dependent kinase to determine cyclin fate during G1 progression |
| Q30583559 | Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling |
| Q34289086 | Cell penetrating peptide inhibitors of nuclear factor-kappa B. |
| Q42834585 | Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation |
| Q44147137 | Characterization of the Ikappa B-kinase NEMO binding domain |
| Q34079481 | Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism |
| Q91651961 | Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas |
| Q33395224 | Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen |
| Q35084291 | Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development |
| Q33975619 | Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance |
| Q28304120 | Critical role of IkappaB kinase alpha in embryonic skin development and skin carcinogenesis |
| Q40555249 | Crosstalk between PKCzeta and the IL4/Stat6 pathway during T-cell-mediated hepatitis |
| Q28256059 | Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism |
| Q37061012 | Cytoplasmic TRADD confers a worse prognosis in glioblastoma |
| Q28267996 | Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer |
| Q28828173 | Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer |
| Q28586470 | Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform |
| Q41890756 | Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice |
| Q40540380 | Detection of IKKbeta-IKKgamma subcomplexes in monocytic cells and characterization of associated signaling |
| Q90707676 | Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome |
| Q40641832 | Differential phosphorylation of the signal-responsive domain of I kappa B alpha and I kappa B beta by I kappa B kinases |
| Q41965715 | Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes. |
| Q61806769 | Dissecting closely linked association signals in combination with the mammalian phenotype database can identify candidate genes in dairy cattle |
| Q36392829 | Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice. |
| Q38356103 | Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. |
| Q37901428 | Estrogen and progesterone in normal mammary gland development and in cancer |
| Q37711321 | Estrogens, regulation of p53 and breast cancer risk: a balancing act. |
| Q37352217 | Evolution of lactation: nutrition v. protection with special reference to five mammalian species |
| Q51825149 | Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic. |
| Q40654612 | Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation |
| Q73922597 | Forced expression of cyclin D1 does not compensate for Id2 deficiency in the mammary gland |
| Q35348210 | From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer |
| Q35659426 | From the ranks of mammary progesterone mediators, RANKL takes the spotlight |
| Q44770240 | Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution |
| Q38330909 | Gene expression profiling in conjunction with physiological rescues of IKKalpha-null cells with wild type or mutant IKKalpha reveals distinct classes of IKKalpha/NF-kappaB-dependent genes |
| Q24794250 | Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression |
| Q35424630 | Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women |
| Q33654930 | Genome wide association study identifies 20 novel promising genes associated with milk fatty acid traits in Chinese Holstein |
| Q35058278 | Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer |
| Q28291669 | Good cop, bad cop: the different faces of NF-kappaB |
| Q40202339 | HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest |
| Q34010730 | Hepatocellular carcinoma and vitamin K. |
| Q38724755 | High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer. |
| Q39804025 | High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer |
| Q38226179 | Hormonal regulation of the immune microenvironment in the mammary gland |
| Q36706104 | I kappa B kinase alpha (IKKα) activity is required for functional maturation of dendritic cells and acquired immunity to infection |
| Q44247178 | IGF-2 is a mediator of prolactin-induced morphogenesis in the breast |
| Q40331218 | IKK alpha regulates estrogen-induced cell cycle progression by modulating E2F1 expression |
| Q35848596 | IKK biology |
| Q40244730 | IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression. |
| Q34177562 | IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. |
| Q38363101 | IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program. |
| Q28475812 | IKKα contributes to canonical NF-κB activation downstream of Nod1-mediated peptidoglycan recognition |
| Q42323488 | IKKα controls ATG16L1 degradation to prevent ER stress during inflammation |
| Q54979518 | IKKα deficiency disrupts the development of marginal zone and follicular B cells. |
| Q53236646 | IKKα promotes intestinal tumorigenesis by limiting recruitment of M1-like polarized myeloid cells. |
| Q36015205 | IKKα-mediated signaling circuitry regulates early B lymphopoiesis during hematopoiesis |
| Q34984184 | IKKα/CHUK regulates extracellular matrix remodeling independent of its kinase activity to facilitate articular chondrocyte differentiation. |
| Q36924500 | Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration |
| Q24802711 | IkB kinase alpha: a link in the chain of the mammary cycle |
| Q36023768 | IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells |
| Q28267530 | IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation |
| Q36637874 | IkappaB kinase complexes: gateways to NF-kappaB activation and transcription |
| Q42957125 | IkappaB kinase subunits alpha and gamma are required for activation of NF-kappaB and induction of apoptosis by mammalian reovirus |
| Q42459866 | IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis |
| Q36289108 | Information networks in the mammary gland. |
| Q40485500 | Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. |
| Q41575754 | Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers |
| Q37907354 | Inhibitory kappa B Kinases as targets for pharmacological regulation |
| Q57807665 | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets |
| Q24800144 | Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function |
| Q36402985 | I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss |
| Q35872007 | IκB kinase alpha and cancer |
| Q38843608 | IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1. |
| Q36882976 | KHF16 is a Leading Structure from Cimicifuga foetida that Suppresses Breast Cancer Partially by Inhibiting the NF-κB Signaling Pathway |
| Q45988712 | Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation. |
| Q36730666 | Macrophage IKKα Deficiency Suppresses Akt Phosphorylation, Reduces Cell Survival, and Decreases Early Atherosclerosis |
| Q37486505 | Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia |
| Q52005562 | Mature T cells depend on signaling through the IKK complex. |
| Q42380563 | MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists |
| Q35671132 | Microarray analysis of the involution switch |
| Q27016106 | Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers |
| Q29547864 | Missing pieces in the NF-kappaB puzzle |
| Q38644746 | Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity. |
| Q58199388 | Molecular dissection of plasmacytoid dendritic cell activation during a viral infection |
| Q35169909 | Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors |
| Q38155200 | Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis |
| Q35408747 | Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. |
| Q36709527 | NF-kappa B as a therapeutic target in neurodegenerative diseases |
| Q35043854 | NF-kappaB activation by protein kinase C isoforms and B-cell function |
| Q35036569 | NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach |
| Q29614603 | NF-kappaB in cancer: from innocent bystander to major culprit |
| Q35592117 | NF-kappaB in mammary gland development and breast cancer |
| Q28205043 | NF-kappaB regulation in the immune system |
| Q40252191 | NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. |
| Q37701897 | NF-kappaB signaling: multiple angles to target OA. |
| Q37431321 | NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer. |
| Q38359190 | NF-κB in cancer therapy. |
| Q35608668 | NF-κB, stem cells and breast cancer: the links get stronger |
| Q36493668 | NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation |
| Q89011918 | Noncanonical NF-κB in Cancer |
| Q28294196 | Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin |
| Q35579356 | Nuclear factor (NF)-kappaB proteins: therapeutic targets |
| Q37164261 | Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo |
| Q29547879 | Nuclear factor-kappaB in cancer development and progression |
| Q35791198 | Nuclear factor-kappaB: its role in health and disease |
| Q34183355 | Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS. The role of Akt, IKKα, and DNA damage repair enzymes. |
| Q36115911 | Nucling, a novel apoptosis-associated protein, controls mammary gland involution by regulating NF-κB and STAT3. |
| Q79204181 | Oncogenes, tumor suppressors and p52 NF-κB |
| Q28504606 | Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis |
| Q41964154 | Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling. |
| Q30434164 | Organogenesis of the exocrine gland |
| Q36848841 | Organotropism of breast cancer metastasis |
| Q24605866 | Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer |
| Q28593804 | Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha |
| Q38764888 | Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage. |
| Q33933774 | Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas |
| Q37352183 | Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability. |
| Q90073087 | Progesterone and Breast Cancer |
| Q38109029 | Progesterone signalling in breast cancer: a neglected hormone coming into the limelight |
| Q36578851 | Progestin-regulated luminal cell and myoepithelial cell-specific responses in mammary organoid culture |
| Q44409381 | Proteotyping of Mammary Tissue from Transgenic and Gene Knockout Mice with Immunohistochemical Markers: a Tool To Define Developmental Lesions |
| Q39055979 | RANK expression on breast cancer cells promotes skeletal metastasis |
| Q28294501 | RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis |
| Q35641868 | RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini |
| Q89666841 | RANKL biology: bone metabolism, the immune system, and beyond |
| Q37865171 | RANKL inhibition: a promising novel strategy for breast cancer treatment. |
| Q37184962 | RANKL stimulates proliferation, adhesion and IL-7 expression of thymic epithelial cells |
| Q47133428 | RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization |
| Q28308042 | RANKL/RANK-beyond bones |
| Q60917149 | RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives |
| Q28075004 | RANKL/RANK: from bone loss to the prevention of breast cancer |
| Q55339749 | RETRACTED: Dissecting closely linked association signals in combination with the mammalian phenotype database can identify candidate genes in dairy cattle. |
| Q42486557 | Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation. |
| Q34616595 | Recent advances in understanding NF-kappaB regulation |
| Q35051324 | Receptor activator for nuclear factor-κB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis |
| Q34302372 | Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2 |
| Q34285636 | Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. |
| Q57093168 | RelB/p50 Dimers Are Differentially Regulated by Tumor Necrosis Factor-α and Lymphotoxin-β Receptor Activation |
| Q34124144 | RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland |
| Q40568050 | Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation. |
| Q89554357 | Review: Following the smoke signals: inflammatory signaling in metabolic homeostasis and homeorhesis in dairy cattle |
| Q24306817 | Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis |
| Q28508088 | Role of F-box protein betaTrcp1 in mammary gland development and tumorigenesis |
| Q37822741 | Role of IKKα in skin squamous cell carcinomas |
| Q36429389 | Role of IkappaB kinase in tumorigenesis |
| Q37241255 | Role of RANKL/RANK in primary and secondary breast cancer |
| Q36324929 | Role of nuclear factor-kappaB in the immune system and bone |
| Q26752576 | Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches |
| Q38068794 | Roles of the Skp2/p27 axis in the progression of chronic nephropathy |
| Q42057315 | Selective inhibition of inhibitory kappa B kinase-beta abrogates induction of nitric oxide synthase in lipopolysaccharide-stimulated rat aortic smooth muscle cells |
| Q29614600 | Shaping the nuclear action of NF-kappaB |
| Q33874455 | Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse |
| Q37225436 | Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer |
| Q40696190 | Signaling intermediates required for NF-kappa B activation and IL-8 expression in CF bronchial epithelial cells |
| Q29616428 | Signalling pathways of the TNF superfamily: a double-edged sword |
| Q35749349 | SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice. |
| Q37020205 | Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation |
| Q36943344 | Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. |
| Q37125950 | Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development |
| Q24317850 | Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicity |
| Q35598825 | Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling |
| Q42050158 | Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. |
| Q34062681 | TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model |
| Q81580785 | TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B |
| Q92513362 | TRAF6 maintains mammary stem cells and promotes pregnancy-induced mammary epithelial cell expansion |
| Q40267440 | Targeted imputation of sequence variants and gene expression profiling identifies twelve candidate genes associated with lactation volume, composition and calving interval in dairy cattle. |
| Q38081245 | Targeting RANKL in breast cancer: bone metastasis and beyond |
| Q34281611 | Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. |
| Q37502685 | Targeting innate immunity protein kinase signalling in inflammation |
| Q38267049 | Targeting the NFκB signaling pathways for breast cancer prevention and therapy. |
| Q98771227 | Targeting the RANKL/RANK/OPG Axis for Cancer Therapy |
| Q39732418 | Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation |
| Q39695870 | The Drosophila atypical protein kinase C-ref(2)p complex constitutes a conserved module for signaling in the toll pathway |
| Q35621375 | The IKK NF-kappa B system: a treasure trove for drug development |
| Q33693802 | The IKK complex, a central regulator of NF-kappaB activation |
| Q28270208 | The IkappaB kinase - a bridge between inflammation and cancer |
| Q24313366 | The IkappaB kinase complex: master regulator of NF-kappaB signaling |
| Q28585870 | The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse |
| Q37109566 | The angiopoietin/Tie2 axis mediates malignant pleural effusion formation |
| Q36752770 | The beginning of the end: death signaling in early involution |
| Q34443090 | The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion |
| Q42454606 | The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population |
| Q34324801 | The carboxyl-terminal region of IkappaB kinase gamma (IKKgamma) is required for full IKK activation |
| Q47167746 | The crossroads of breast cancer progression: insights into the modulation of major signaling pathways |
| Q44295950 | The donor splice site mutation in NFkappaB-inducing kinase of alymphoplasia (aly/aly) mice |
| Q40696432 | The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways |
| Q34114512 | The nuclear factor NF-kappaB pathway in inflammation |
| Q36955377 | The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis |
| Q55117611 | Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment. |
| Q89509415 | Toll-like Receptors from the Perspective of Cancer Treatment |
| Q34786668 | Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity |
| Q38065965 | Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype |
| Q40478629 | Tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells mediated through IKK. |
| Q35194008 | Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling |
| Q28565703 | Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines |
| Q33733718 | Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. |
| Q41182821 | Understanding the Inguinal Sinus in Sheep (Ovis aries)-Morphology, Secretion, and Expression of Progesterone, Estrogens, and Prolactin Receptors |
| Q36637897 | Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. |
| Q39454841 | Up-regulation of Cks1 and Skp2 with TNFα/NF-κB signaling in chronic progressive nephropathy |
| Q39995123 | Zoledronic acid is effective against experimental malignant pleural effusion. |
| Q89018067 | cIAP2 Is an Independent Signaling and Survival Factor during Mammary Lactational Involution and Tumorigenesis |
| Q24630517 | poky/chuk/ikk1 is required for differentiation of the zebrafish embryonic epidermis |
Search more.